Recent Updates
Recently added Catalysts
APLS

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Key Takeaway: WALTHAM, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences in September: Citi 17th Annual Bi

Full Press Release Details

WALTHAM, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences in September:
Citi 17th Annual BioPharma Conference: Fireside chat on Wednesday, September 7, 2022 at 1:00 p.m. ET.
Wells Fargo Healthcare Conference: Fireside chat on Thursday, September 8, 2022 at 1:55 p.m. ET.
Baird 2022 Global Healthcare Conference: Presentation on Wednesday, September 14, 2022 at 3:10 p.m. ET.
BofA Global Research Global Healthcare Conference 2022: Presentation on Friday, September 16, 2022 at 3:05 p.m. BST / 10:05 a.m. ET.
The conference events will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. Replays of the webcasts will be available for 30 days following the event.
Last updated: Sep 1, 2022